Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels

• Status: Completed
• Trial end date: 2010-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to compare the efficacy and safety profiles of Perrigo Israel Pharmaceuticals, Ltd. Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel and Benzaclin® Topical Gel (Clindamycin- Benzoyl Peroxide Gel).

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Padagis LLC; Perrigo Company
• Treatments: Benzoyl Peroxide; Clindamycin; Clindamycin palmitate; Clindamycin phosphate

Criteria

Inclusion Criteria:

• Healthy men or women, 12 to 65 years of age

• Willing to participate and sign provide written consent

• Moderate to severe acne

Exclusion Criteria:

• Pregnant or lactating women

• History of unresponsiveness or hypersensitivity to clindamycin, benzoyl peroxide or lincomycin

• Use of systemic, topical or facial products which may interfere with the study

• Participation in any clinical study in the 30 days prior to study entry

• Prolonged exposure to sunlight or excessive exposure to UV lights

• Chronic use of NSAIDS